Potentiation of haloperidol catalepsy by microinjections of nicotine into the striatum or pons in rats

Life Sciences

Volumn 64, Issue 13, 1999, Pages 1117-1125

  Elazar, Zeev ^a   Paz, Milka ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Catalepsy; Haloperidol; Nicotine; Ports; Striatum

Indexed keywords

CARBACHOL; HALOPERIDOL; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORPUS STRIATUM; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG POTENTIATION; GILLES DE LA TOURETTE SYNDROME; INTRACEREBRAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICROINJECTION; NONHUMAN; PONS RETICULAR FORMATION; RAT; TREATMENT OUTCOME;

ANIMALS; CATALEPSY; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HALOPERIDOL; MALE; MICROINJECTIONS; NICOTINE; RATS; RETICULAR FORMATION;

ANIMALIA;

EID: 0033582730     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00040-5     Document Type: Article

References (32)

1. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W Ruddon and A. Goodman-Gilman, The Pharmacological Basis of Therapeutics, Pergamon Press, N.Y. (1996).
2. R. Erdmann, Fortsch. Neurol. Psychiatr. 64 362-366 (1996).
3. B.J. McConville, H.M. Fogelson, A.B. Norman, W.M. Klykylo, P.Z. Manderscheid, K.W. Parker and P.R. Sanberg, Am. J. Psychiatry 148 793-794 (1991).
4. P.R. Sanberg, H.M. Fogelson, P.Z. Manderscheid, K.W Parker, A.B. Norman and B.J. McConville, Lancet 1 592 (1988).
5. A.A. Silver and P.R. Sanberg, Lancet 342 182 (1993).
6. S.M. Dursum and M.A. Reveley, Psychol. Med. 27 483-487 (1997).
7. R.D. Shytle, A.A. Silver, M.K. Philipp, B.J. McConville and P.R. Sanberg, Drug Development Res. 38 290-298 (1996).
8. D.F. Emerich, M.D. Zanol, A.B. Norman, B.J. McConville and P.R. Sanberg, Pharmacol. Biochem. Behav. 38 875-880 (1991).
9. P.R. Sanberg, D.F. Emerich, M.M. El-Etri, M.T Shipley, M.D. Zanol, D.W. Cahill and A.B. Norman, Pharmacol. Biochem. Behav. 46 303-307 (1993).
10. B. Costall, R.J.Naylor and J.E. Olley, Neuropharmacol. 11 645-663 (1972).
11. B. Costall and R.J. Naylor, Arzneim Forsch. 23 674-683 (1973).
12. Z. Elazar and M. Paz, Neurosci. Lett. 115 226-230 (1990).
13. Z. Elazar and M. Paz, Life Sci. 51 1373-1380 (1992).
14. Z. Elazar, D. Ganchrow and M. Paz, Naunyn-Schmiedeberg's Arch.Pharmacol. 356 166-172 (1997).
15. Z. Elazar, D. Ganchrow, M. Paz, R. Rabinowitz and A.D. Korczyn, Neurosci. Lett. 119 245-248 (1990).
16. Z. Elazar, N. Peleg, M. Paz and G. Ring, Naunyn-Schmiedeberg's Arch. Pharmacol. 352 187-193 (1995).
17. B. Ellenbroek, M. Schwartz, K.H. Sontag, R. Jaspers and A. Cools, Brain Res. 345 132-140 (1985).
18. G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York (1982).
19. P.R. Sanberg, M. Giordano, M.D. Bunsey and A.B. Norman, Behav. Neurosci. 102 748-759 (1988).
20. M. De Ryck, T. Schallert and P. Teitelbaum, Brain Res. 201 143-172 (1980).
21. B. Costall and J.E. Olley, Neuropharmacol. 10 297-306 (1971).
22. W. Turski, S.J. Czuczwar, L. Turski and Z. Kleinrok, Meth. and Find. Exptl. Clin. Pharmacol. 4 287-291 (1982).
23. M.E. Castello, B. Bolioli and F. Dajas, Pharmacol. Biochem. Behav. 41 547-550 (1992).
24. G. Zetler, Neuropharmacol. 10 289-296 (1971).
25. A. Greene, U. Gerber and R.W. McCarley, Brain Res. 476 154-159 (1989).
26. D.R. Stevens, S. Birnstiel, U. Gerber, R.W. McCarley and R.W. Greene, Neurosci. 57 419-429 (1993).
27. J. Velazquez-Montezuma, M.D. Shalauta, J.C. Gillin and P.J. Shiromani, Neurosci. Lett. 115 265-268 (1990).
28. R. Dunstan, C.L. Broekkamp and K.G. Lloyd, Pharmacol. Biochem. Behav. 14 169-174 (1981).
29. P. Seeman, Pharmacol. Rev. 32 229-313 (1981).
30. E.N. Peterson, Europ. J. Pharmacol. 69 339-405 (1981).
31. M. Steriade and J.A. Hobson, Prog. Neurobiol. 6 155-376 (1976).
32. M.J. Bier and R.W. McCarley, Brain Res. 634 333-338 (1994).